Exelixis | EXEL - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
Amgen USD 195.44B 5.55B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Exelixis USD 13.54B 2.65B 2026-06
Genmab DKK 17.1B 88.06B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MacroGenics USD 184M 82M 2026-03
Merck USD 317.37B 20.27B 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Xencor USD 1.19B 301M 2026-06